Argenziano ME, Kim MN, Montori M, Di Bucchianico A, Balducci D, Ahn SH, et al. Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients. Hepatol Int. 2024;18(Suppl 2):922–40. https://doi.org/10.1007/s12072-024-10692-4.

Article  PubMed  Google Scholar 

Liu K, Ou JJ. Regulators of HCC stem cells. World J Stem Cells. 2021;13(8):1127–33. https://doi.org/10.4252/wjsc.v13.i8.1127.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin J, Rao D, Zhang M, Gao Q. Metabolic reprogramming in the tumor microenvironment of liver cancer. J Hematol Oncol. 2024;17(1):6. https://doi.org/10.1186/s13045-024-01527-8.

Article  PubMed  PubMed Central  Google Scholar 

Caini P, Carloni V. Metabolism and immune suppressive response in HCC. 2025; 13(6). https://doi.org/10.3390/biomedicines13061461.

Zheng J, Wang S, Xia L, Sun Z, Chan KM, Bernards R. Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal Transduct Target Ther. 2025;10(1):35. https://doi.org/10.1038/s41392-024-02075-w.

Article  PubMed  PubMed Central  Google Scholar 

Huang F, Chen L, Zhang X, Tian S, Han Y, Hu M, et al. Engineered nanomedicine targets HCC stem cells to treat HCC disease. J Mater Chem B. 2025;13(41):13184–205. https://doi.org/10.1039/d5tb01278c.

Article  CAS  PubMed  Google Scholar 

Xia P, Liu DH. Cancer stem cell markers for HCC and pancreatic cancer. Stem Cell Res. 2022;60:102701. https://doi.org/10.1016/j.scr.2022.102701.

Article  CAS  PubMed  Google Scholar 

A-Y KKW, Shang Y, Wijerathne CUB, Madduma Hewage S, S YL, O K. Acute Kidney injury induces oxidative stress and hepatic lipid accumulation through AMPK signaling pathway. Antioxid (Basel). 2023;12(4). https://doi.org/10.3390/antiox12040883.

Zhang B, Lu J, Jiang Y, Feng Y. Asprosin contributes to nonalcoholic fatty liver disease through regulating lipid accumulation and inflammatory response via AMPK signaling. Immun Inflamm Dis. 2023;11(8):e947. https://doi.org/10.1002/iid3.947.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang JX, Feng WJ, Liu GC, Ma QQ, Li HL, Gao XY, et al. Corosolic Acid Attenuates Hepatic Lipid Accumulation and Inflammatory Response via AMPK/SREBPs and NF-kappaB/MAPK Signaling Pathways. Am J Chin Med. 2020;48(3):579–95. https://doi.org/10.1142/S0192415X20500299.

Article  CAS  PubMed  Google Scholar 

Yin X, Liu Z, Wang J. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis. Phytomedicine. 2023;119:155005. https://doi.org/10.1016/j.phymed.2023.155005.

Article  CAS  PubMed  Google Scholar 

Weng SY, Schuppan D. AMPK regulates macrophage polarization in adipose tissue inflammation and NASH. J Hepatol. 2013;58(3):619–21. https://doi.org/10.1016/j.jhep.2012.09.031.

Article  CAS  PubMed  Google Scholar 

Ma W, Wang Y, Liu J. NLRP3 Inflammasome Activation in Liver Disorders: From Molecular Pathways to Therapeutic Strategies. J Inflamm Res. 2025;18:8277–94. https://doi.org/10.2147/JIR.S532908.

Article  PubMed  PubMed Central  Google Scholar 

Yu T, Luo L, Xue J, Tang W, Wu X, Yang F. Gut microbiota-NLRP3 inflammasome crosstalk in metabolic dysfunction-associated steatotic liver disease. Clin Res Hepatol Gastroenterol. 2024;48(8):102458. https://doi.org/10.1016/j.clinre.2024.102458.

Article  CAS  PubMed  Google Scholar 

Kaufmann B, Leszczynska A, Reca A, Booshehri LM, Onyuru J, Tan Z. NLRP3 activation in neutrophils induces lethal autoinflammation, liver inflammation, and fibrosis. EMBO Rep. 2022;23(11):e54446. https://doi.org/10.15252/embr.202154446.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim ME, Lee JS, Kim TW, Park MH, Kim DH. FoxO6-Mediated TXNIP induces lipid accumulation in the liver through NLRP3 inflammasome activation. Endocrinol Metab (Seoul). 2024;39(1):127–39. https://doi.org/10.3803/EnM.2023.1826.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pham TH, Lee GH, Jin SW, Lee SY, Han EH, Kim ND, et al. Sesamin ameliorates lipotoxicity and lipid accumulation through the activation of the estrogen receptor alpha signaling pathway. Biochem Pharmacol. 2023;216:115768. . https://doi.org/10.1016/j.bcp.2023.115768.

Article  CAS  PubMed  Google Scholar 

Zhou LM, Fan JH, Xu MM, Xiong MY, Wang QJ, Chai X. Epiberberine regulates lipid synthesis through SHP (NR0B2) to improve non-alcoholic steatohepatitis. Biochim Biophys Acta Mol Basis Dis. 2023;1869(4):166639. https://doi.org/10.1016/j.bbadis.2023.166639.

Article  CAS  PubMed  Google Scholar 

Wang HW, Kok SH, Yang CN, Hong CY, Chi CW, Chen MH, et al. Blockade of fatty acid signalling inhibits lipopolysaccharide-induced macrophage recruitment and progression of apical periodontitis. Int Endod J. 2021;54(6):902–15. https://doi.org/10.1111/iej.13468.

Article  PubMed  Google Scholar 

Wang QY, Liu YJ, Hu Y, Xiao H, Xia LL, Wu YG. Prognostic and immune roles of UROC1 in human cancers: from mechanism exploration of NAFLD and HCC to pan-cancer analysis. Eur Rev Med Pharmacol Sci. 2024;28(2):622–44. https://doi.org/10.26355/eurrev_202401_35059.

Article  PubMed  Google Scholar 

Shao G, Yun X, Xie H, Sun B. Mendelian randomization analysis of inflammatory biomarkers and hepatocellular carcinoma risk: genetic causality and single-cell transcriptomics. Discov Oncol. 2025;16(1):1500. https://doi.org/10.1007/s12672-025-03357-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weng J, Wang Z, Hu Z, Xu W, Sun JL, Wang F, et al. Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy. Cancer Res. 2024;84(11):1817–33. https://doi.org/10.1158/0008-5472.CAN-23-3106.

Article  CAS  PubMed  Google Scholar 

Du L, Ji Y, Xin B, Zhang J, Lu LC, Glass CK, et al. Shp2 Deficiency in Kupffer Cells and Hepatocytes Aggravates Hepatocarcinogenesis by Recruiting Non-Kupffer Macrophages. Cell Mol Gastroenterol Hepatol. 2023;15(6):1351–69. https://doi.org/10.1016/j.jcmgh.2023.02.011.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matsumoto S, Kikuchi A. Wnt/beta-catenin signaling pathway in liver biology and tumorigenesis. Vitro Cell Dev Biol Anim. 2024;60(5):466–81. https://doi.org/10.1007/s11626-024-00858-7.

Article  CAS  Google Scholar 

Deldar Abad Paskeh M, Mirzaei S, Ashrafizadeh M, Zarrabi A, Sethi G. Wnt/beta-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways. J Hepatocell Carcinoma. 2021;8:1415–44. https://doi.org/10.2147/JHC.S336858.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Catalano T, Selvaggi F, Esposito DL, Cotellese R, Aceto GM. Infectious Agents Induce Wnt/beta-Catenin Pathway Deregulation in Primary HCCs. Microorganisms. 2023;11(7). https://doi.org/10.3390/microorganisms11071632

Wang K, Qiu X, Zhao Y, Wang H, Chen L. The Wnt/beta-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma. Cancer Biol Med. 2021;19(3):305–18. https://doi.org/10.20892/j.issn.2095-3941.2021.0306.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen JQ, Lan X. Calculus bovis inhibits HCC via the Wnt/beta-catenin pathway. World J Gastroenterol. 2025;31(9):99459. https://doi.org/10.3748/wjg.v31.i9.99459.

Article  PubMed  PubMed Central  Google Scholar 

Yao CY, Tao HT, He JJ, Zhu FY, Xie CQ, Cheng YN, et al. NUAK1 acts as a novel regulator of PD-L1 via activating GSK-3beta/beta-catenin pathway in hepatocellular carcinoma. Mol Med. 2025;31(1):38. https://doi.org/10.1186/s10020-025-01088-7.

Article  CAS  PubMed  PubMed Central